E

Eidos Therapeutics

50 employees

Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2016

Funding rounds raised

Total raised

$64M

from 5 investors over 5 rounds

E

Eidos Therapeutics raised $64M on April 5, 2018

Investors: Aisling Capital, BridgeBio, Viking Global Investors, RA Capital Management, L.P. and Perceptive Advisors

FAQ